CHROMADEX CORPORATION, Issuer AND [TRUSTEE], Trustee INDENTURE Dated as of [●], 20__ Debt SecuritiesIndenture • June 12th, 2020 • ChromaDex Corp. • Medicinal chemicals & botanical products • New York
Indenture, dated as of [●], 20__, among ChromaDex Corporation, a Delaware corporation (the “Company”), and [Trustee], as trustee (the “Trustee”):
ChromaDex Corporation and _____________, As Warrant Agent Form of Debt Securities Warrant Agreement Dated As Of __________ ChromaDex Corporation Form of Debt Securities Warrant AgreementWarrant Agreement • June 12th, 2020 • ChromaDex Corp. • Medicinal chemicals & botanical products • New York
This Debt Securities Warrant Agreement (this “Agreement”), dated as of [●], between ChromaDex Corporation, a Delaware corporation (the “Company”), and [●], a [corporation] [national banking association] organized and existing under the laws of [●] and having a corporate trust office in [●], as warrant agent (the “Warrant Agent”).
CHROMADEX CORPORATION Common Stock (par value $0.001 per share) At Market Issuance Sales AgreementAt Market Issuance Sales Agreement • June 12th, 2020 • ChromaDex Corp. • Medicinal chemicals & botanical products • New York
ChromaDex Corporation and _____________, As Warrant Agent Form of Common Stock Warrant Agreement Dated As Of __________ ChromaDex Corporation Form of Common Stock Warrant AgreementWarrant Agreement • June 12th, 2020 • ChromaDex Corp. • Medicinal chemicals & botanical products • New York
This Common Stock Warrant Agreement (this “Agreement”), dated as of [●], between ChromaDex Corporation, a Delaware corporation (the “Company”), and [●], a [corporation] [national banking association] organized and existing under the laws of [●] and having a corporate trust office in [●], as warrant agent (the “Warrant Agent”).
